Hubei Goto Biopharm Co.,Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 588.37 million compared to CNY 464.71 million a year ago. Revenue was CNY 590.89 million compared to CNY 468.12 million a year ago. Net income was CNY 78.33 million compared to CNY 53.29 million a year ago. Basic earnings per share from continuing operations was CNY 0.74 compared to CNY 0.62 a year ago. Diluted earnings per share from continuing operations was CNY 0.74 compared to CNY 0.62 a year ago.